To validate the role of CIP2A signaling in mediating the apoptotic effect of bortezomib in breast cancer cells, we first generated MDA-MB- 231-CIP2A and MDA-MB-468-CIP2A cells which constitutively express ectopic CIP2A (Figure 3A). Here, CIP2A is linked to breast carcinoma.